1 Product identity
Ingredient risk
Contains restricted ingredients
Chemical X
BrandChaos and Pain→Other Combinations Tablet or Pill 15 ingredients 2 banned 1 caution DSLD #209906Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2019-12-22
2 Ingredients (15)
IngredientGroupSafety
19-NorAndrost-4-ene-3b-ol, 17-one19-NorAndrost-4ene-3b-ol,17-one—
Fadogia agrestisFadogia agrestis—
5a-HydroxylaxogeninLaxogenin—
Hydroxypropyl-Beta-CyclodextrinHydroxypropyl Beta Cyclodextrin—
PhytosterolPhytosterol (unspecified)—
Stearic AcidStearic Acid—
StarchStarch—
FD&C colorColor—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
DHEA 🇨🇦 🇬🇧 🇪🇺 🇦🇺 — Not approved for OTC sale as supplement.
Titanium Dioxide 🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
DHEA — Limited Evidence
⚠ Hormonal: acne, hirsutism, voice deepening
⚠ May promote hormone-sensitive cancers
Choline — Limited Evidence
⚠ Fishy odor at high doses
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Titanium Dioxide — Banned in ≥1 country
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID209906
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2019-12-22
6 More from Chaos and Pain
View Chaos and Pain Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Chemical X — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 29]. Available from: https://supplement.ge/products/chemical-x-209906/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG